You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, February 2007
|
| DOI | 10.1007/s10549-006-9463-x |
| Pubmed ID | |
| Authors |
Richard S. Finn, Judy Dering, Charles Ginther, Cindy A. Wilson, Padraic Glaspy, Nishan Tchekmedyian, Dennis J. Slamon |
Mendeley readers
The data shown below were compiled from readership statistics for 197 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 3% |
| United Kingdom | 2 | 1% |
| France | 1 | <1% |
| Australia | 1 | <1% |
| Switzerland | 1 | <1% |
| Germany | 1 | <1% |
| Brazil | 1 | <1% |
| Japan | 1 | <1% |
| Belgium | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 183 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 45 | 23% |
| Student > Ph. D. Student | 44 | 22% |
| Student > Doctoral Student | 15 | 8% |
| Student > Bachelor | 13 | 7% |
| Professor > Associate Professor | 13 | 7% |
| Other | 42 | 21% |
| Unknown | 25 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 71 | 36% |
| Biochemistry, Genetics and Molecular Biology | 38 | 19% |
| Medicine and Dentistry | 38 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Chemistry | 6 | 3% |
| Other | 10 | 5% |
| Unknown | 25 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2023.
All research outputs
#4,749,004
of 22,994,508 outputs
Outputs from Breast Cancer Research and Treatment
#898
of 4,677 outputs
Outputs of similar age
#22,406
of 161,419 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#7
of 35 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,677 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,419 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.